Tuberous sclerosis complex with multisystem manifestations.

Li, M D; Yu, Q; Fu, J L; Li, Y R; Shi, G

Li, M D; Yu, Q; Fu, J L; Li, Y R; Shi, G.

Afiliación

Li MD; Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Yu Q; Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Fu JL; Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Li YR; Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Shi G; Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.

J Biol Regul Homeost Agents ; 34(3): 1045-1047, 2020.

Article en En | MEDLINE | ID: mdl-32660214

Asunto(s)

Esclerosis Tuberosa; Humanos; Mutación; Esclerosis Tuberosa/genética; Proteínas Supresoras de Tumor/genética

Palabras clave

TSC1; TSC2; tuberous sclerosis complex

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Tuberosa Límite: Humans Idioma: En Revista: J Biol Regul Homeost Agents Asunto de la revista: BIOLOGIA / BIOQUIMICA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google